Plasmid Profile Analysis of Pseudomonas aeruginosa Isolated from Wound Infections in a General Hospital in Southern Nigeria

Main Article Content

F. Z. Uyanga
I. A. Ibanga

Abstract

Background/Purpose: Open wound infection is a serious problem especially with extended-spectrum beta lactamase (ESBL) producing Gram negative bacteria such as P. aeruginosa. The purpose of this research was to identify open wound infections due to Pseudomonas aeruginosa and also determine their plasmid profile.

Methods:  A total of 50 Pseudomonas aeruginosa isolates were obtained from clinical wound swabs in a secondary health care facility. Pseudomonas aeruginosa isolates were identified using Microbact 24E system kit. Pseudomonas aeruginosa were isolated and subjected to antibiotic susceptibility testing by disc diffusion method. ESBL production was detected using Double Disk Synergy Test (DDST) and CHROMagar ESBL (France). Six different antibiotic discs were used to determine the susceptibility pattern of the isolates. Plasmids were extracted using ZR plasmid Miniprep classic extraction Kit. Electrophoresis of the DNA was carried out on 0.8% w/v agarose gel.

Results: The prevalence of Pseudomonas aeruginosa was 63%. The antibiotic resistance pattern showed that Pseudomonas aeruginosa was highly resistant against cefotaxime (90%), ofloxacin (80%), ceftazidime (55%), azetronam (60%), imipenem (25%), amoxicillin clavulanic acid (35%) and amikacin (30%). Plasmid profile was carried out on 20 selected multidrug resistant isolates; those resistant to three or more classes of antibiotics. Plasmid content of the isolates were found to be 90%. All isolates that had plasmid were resistant to cefotaxim, ceftazidime, azetronam, ofloxacin and amikacin.

Conclusion: Antibiotic resistance by P. aeruginosa is increasingly high in wound infections and appears to be linked to the presence of plasmid and ESBL enzymes.

Keywords:
P. aeruginosa, plasmid profile multidrug resistance.

Article Details

How to Cite
Uyanga, F. Z., & Ibanga, I. A. (2019). Plasmid Profile Analysis of Pseudomonas aeruginosa Isolated from Wound Infections in a General Hospital in Southern Nigeria. Journal of Advances in Microbiology, 18(3), 1-7. https://doi.org/10.9734/jamb/2019/v18i330171
Section
Original Research Article

References

Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis. 2002;34:634-640.

Olorunfemi PO, Onaolapo JA. Comparative activities of home commonly used antibacterial agents on S. aureus, E. coli and P. aeruginosa. Nigerian Journal of Pharmaceutical Sciences. 1988;4:53-57.

Hancock RE, Speert DP. Antibiotic resistance in Pseudomonas aeruginosa Mechanisms and Impact on Treatment Drug Resist Update. 2000;3:247- 55.

National Nosocomial Infections Surveillance System. NNIS report, data summary from Jan 1990- May 1999. Am J Infect Contr. 1999;27:520-532.

Alexander MF. Wound infection. In: Alexander MF, Fawcett JN, Runciman PJ (eds). Nursing practice hospital and home, the adult. London, UK: Churchill Livingstone. 1994;703.

KO O, et al. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from clinical specimens in a Tertiary Hospital in Northeastern Nigeria. The Internet Journal of Microbiology. 2009;8(2):1235-1240.

Bonfiglio G, Laksai Y, Franchino L, et al. Mechanism of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. Journal of Antimicrobial Chemotherapy. 1998;42: 697-702

Samporn S, Chuntima T, Thitiya Y, Chertask D. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type. Southeast Asia Journal of Tropical Medicine and Publichealth. 2004;35:893-894.

Qarah S, Cunha AB, Dua P, et al. Pseudomonas aeruginosa infections; 2008.
Available:http://www.emedicine.com/med/topic1943.html

Shittu AO, Kolawole OD, Oyedepo RE. Wound infections in two health institutions in Ile-Ife, Nigeria: Results of a cohort study. Osteology Wound Management. 2004;49 (5):1630 -1635.

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC Definitions for nosocomial infections. Am J Infect Control. 1988;16(3):232.

Brook RD, Bard RL, Burnett RT, Shin HH, Vette A, Croghan C, et al. Differences in blood pressure and vascular responses associated with ambient fine particulate matter exposures measured at the personal versus community level. Occup. Environ. Med. 2011;68(3):224–230.

Clinical and Laboratory Standard Institute Antimicrobial Susceptibility Testing Standard. 28th edition, M02, MO7 and M011; 2018.

Brown A, O’ Brien S, Cocks S, Beares J, Dimmer SA. Laboratory evaluation of chromogenic screening media for the detection of ESBL producing bacteria. United Kingdom: Oxoid Ltd.1; 2011.

Gazin M, Paasch F, Goostens H, Malhotra-Kumar S. Current trends in culture based and molecular detection of extended spectrum β-lactamase harbouring and Carbapenem – resistant Enterobacteriaceae. J Clin Microbiol. 2012; 50(4):1140-1146.

Ravi S, Namratha W, Chandraskhar MR. Comparison of disc diffusion method for the detection of extended-spectrum beta lactamase-producing enterobacteriaceae. Journal of Laboratory Physicians. 2011;3 (1):33-36.

Marian RR, Mohamed S, Hazim AR, Noha AH. High incidence of MBL-mediated imipenem resistance among Pseudomonas aeruginosa from surgical site infections in Egypt. Journal of Infections in Developing Countries. 2018; 12:520-525.

Gad GF, El. Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007;60:1010-1017

Leila Y, Hajieh S, Iraj N, Hamid RA, Fatemeh A, Seyed E, Mohammad I, Bahman C, Saeed H. Incidence and risk factors of diabetic foot ulcer: A population-based diabetic foot cohort (ADFC study)—Two-year follow-up study article, International Journal of Endocrinology. 2018;9.
[ID 7631659]
Available:https://doi.org/10.1155/2018/7631659

Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007;60:1010-1017

Hassuna NA, Mohamed AHI, Abo-Eleuoon SM, Rizk HA WA. High prevalence of multidrug resistant Pseudomonas aeruginosa recovered from infected burn wounds in children. Arch Clin Microbiol. 2015;6:1-7.

Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Resistance to Tetracycline, chloramphenicol and norfloxacin. Antimicrob Agents Chemother, 1994;38(8):1732-1741.

Aboderin BW, Motayo BO, Ibeh I, Adeyakinu FO, Ogiogwa IJ, Adebgoyega TT, Olowe O. Detection of Extended spectrum Beta lactamase producing strains of E. coli and Klebsiella spp. in a tertiary hospital in Abeokuta Ogun State. Nig J of Clin and Biomed Res. 2010;14: (9):1835-1839.

Yoon MY, Lee K, Jeong SH, Kim J, Yoon SS. Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients. J Microbiol. 2010;48: 518 –525.

Daini OA, Effiong MJ, Ogbolu OD. Quinolones resistance and R-plasmids of clinical isolates of Pseudomonas species. Sudan J. M. Sci. 2008;3: 139-146.

Akingbade OA, Balogun SA, Ojo D, Afolabi RO, Motayo BO, Okerentugba PO. Okonko IO. Plasmid profile analysis of multidrug resistant Pseudomonas aeruginosa isolated from wound infections in South West, Nigeria. World Applied Science Journal (In press); 2012.

Ongut G, Dalogle AE, Bayson BO, Daglar D, Ogunc D, Sekercioglu AO. Evaluation of a chromogenic medium for detection of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae strains. Clin Lab. 204;60: 1213-1215.

Asad UK, Lubna M, Raffaelle Z. Structure genetics and world wide spread of new Delhi Metallo-Beta-lactamase (NDM-1): A threat to public health. BMC Microbiology. 2017;17;101.

Ravi S, Namratha W, Chandraskhar MR. Comparison of disc diffusion method for the detection of extended-spectrum beta lactamase-producing enterobacteriaceae. Journal of Laboratory Physicians. 2011;3 (1):33-36.

Bradford PA. Extended-spectrum beta-lactamases in the 21st century: Antimicrobial Agents and Chemotherapy. 2001;32:2227-2238.

Marhova K, Kostadinova T, Stoitos M. ESBL: An increasing threat. Antimicrobial Agent and Chemotherapy. 2009;15:375-379.

Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-b-lactamases: The quietbefore storm? Clin Microbiol Rev. 2005;18:306-325.

Olayinka AT, Olayinka BO, Onile BA. Antibiotic susceptibility and plasmid pattern of Pseudomonas aeruginosa from the surgical unit of a University Teaching Hospital in North Central, Nigeria. Int. J. Med. Med. Sci. 2009;1:79-83.

Yimaz A, Cobian AY, Yelz Y, Tamverdi C, Yidrim TT, Erturan ZZ, Dunipnar BB, Bozdogan BB. Investigation of plasmid Mediated quinolone resistance in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Microbiol. Bull. 2011;45:602-608.